OTC Markets Stock News
All posts tagged "CYDY"
-
4.8K1BiotechCytoDyn (OTCMKTS: CYDY) Accelerates Recruitment to 250 Patients in Pivotal COVID-19 Trial
CytoDyn Inc. (OTCMKTS:CYDY) on a conference call yesterday revealed that approximately 250 patients have been recruited in their CD12 severe to critical...
-
9.8K1BiotechAll Eyes On CytoDyn Now That Trump Has COVID-19
Just now, markets are waking up to the news that President Donald Trump and First Lady Melanie have tested positive for COVID-19....
-
23.7K1BiotechCytoDyn (OTCMKTS:CYDY) May Make the White House Podium
CytoDyn Inc. (OTCMKTS:CYDY) may be the target of a White House press briefing very soon. A couple of social media influencers like...
-
15.5K2BiotechWading through the STAT News FUD Attack on CytoDyn Inc. (OTCMKTS: CYDY)
CytoDyn Inc. (OTCMKTS: CYDY) announced superb top-line data in their mild to moderate COVID-19 phase 2 trial and did not disappoint; however,...
-
28.5K1BiotechCytoDyn’s (OTCMKTS: CYDY) Strong Safety Data in Mild to Moderate Smokes Gilead (NASDAQ: GILD) & Crushes Endpoint Leading to the First Potential COVID-19 Approval
CytoDyn Inc. (OTCMKTS: CYDY) announced groundbreaking safety results from its phase 2 Mild to Moderate COVID-19 trial today. The company reported a...
-
12.8K1BiotechCytoDyn (OTCMKTS: CYDY) Bolts Higher On Mexican Approval Chatter
Yesterday CytoDyn Inc. (OTCMKTS: CYDY) moved up 27% on the completion of a Memorandum of Understanding with the NIH of Mexico to...
-
11.3K1BiotechGilead (NASDAQ: GILD) Shares Jump On Trial Results and Fauci Despite 9.3% Mortality Rate After 14 Days
Today Gilead Sciences (NASDAQ: GILD) was making a splash about their phase 3 trial results but all this trial essentially did was...
-
25.8KBiotechUK Prime Minister Boris Johnson Linkage to CytoDyn (OTCMKTS: CYDY) Evolving
CytoDyn Inc. (OTCMKTS: CYDY) announced today it was collaborating with the United Kingdom’s Department of Health to provide emergency access to leronlimab...
-
14.5KBiotechBACK TO WORK ORDER COMING – Courtesy of CytoDyn (OTCMKTS: CYDY)
Blood Race to Identify the COVID-19 Uninfected Cytodyn Inc. (OTCMKTS: CYDY) has a drug that could beacon the call back to work. ...
-
10.0KBiotechBioxtyran (OTCMKTS: BIXT) Licenses Phase 2 Asset for COVID-19 Patients After Finding Smoking Gun Journal Article
Bioxytran Inc. (OTCMKTS: BIXT) has a development stage hypoxia drug that that was initially targeting Acute Respiratory Distress Syndrome (ARDS) and stroke. ...
